Clinicians attending a meeting on spinal muscular atrophy (SMA) research in Dallas, TX, share what they learned and how it impacts clinical care. The cutting-edge research that is being done on SMN1 and other therapeutic targets is driving a change in standards of care. Review these short videos in 30 minutes for free CME and be up-to-date on the latest from this national meeting.